Shelter Pharma's 14 Veterinary Products Selected for Supply to AMUL
Shelter Pharma Limited announced that 14 of its veterinary products have been chosen for supply to Gujarat Co-operative Milk Marketing Federation Ltd. (AMUL). This selection marks a significant advancement for Shelter Pharma in the animal healthcare sector, particularly in the dairy industry. The company's management anticipates this partnership with AMUL to positively impact their business prospects in the animal healthcare segment. The selection also highlights Shelter Pharma's commitment to providing high-quality Ayurvedic welfare solutions for animals.
Shelter Pharma's Board of Directors has approved the allotment of 88,08,000 convertible share warrants at Rs 42.25 per warrant, raising Rs 37.21 crore. The warrants are issued to both promoter and non-promoter investors, with 34.09% allocated to the promoter group and 65.91% to non-promoters. The company has received an upfront payment of Rs 9.30 crore, with the remaining amount due upon conversion within 18 months. Notable allottees include Zubedabibi Nisarahmed Sabugar from the promoter group and Managing Director Mustaqim Nisarahmed Sabugar.
Shelter Pharma Limited received unanimous shareholder approval for issuing up to 91.02 lakh convertible equity share warrants at ₹42.25 each, potentially raising ₹38.46 crore. The decision was made during an EGM on July 23, 2025, with 54.97% of total shares represented in voting. The warrants, convertible into one equity share each, will be issued to promoter and non-promoter investors via private placement. This capital raise aligns with the company's growth strategies in the pharmaceutical sector.
23Jul 25
Shelter Pharma Approves ₹38.46 Crore Warrant Issue in EGM
Shelter Pharma Limited held an EGM on July 23, 2025, to approve the issuance of up to 91,02,000 Convertible Equity Share Warrants at ₹42.25 per warrant. The total value of the issue could reach ₹38,45,59,500. The warrants, convertible into one equity share each, will be issued to both Promoter Group and Non-Promoters on a private placement and preferential basis. The company's Managing Director, Mr. Mustaqim Nisarahmed Sabugar, stated that the funds would support future prospects. Voting results are expected within 48 hours of the meeting's conclusion.